Clinical Research Facility

Cedarhurst, New York 11516

We've found

2 trials

at this facility

Efficacy and Safety of Adjunctive Pimavanserin for the Treatment of Schizophrenia (ENHANCE-1)

Status: Enrolling, Phase III
Updated: 12/31/1969

from

Cedarhurst, NY

A Study to Evaluate the Safety and Efficacy of BIIB104 in Participants With Cognitive Impairment Associated With Schizophrenia (CIAS)

Status: Enrolling, Phase II
Updated: 12/31/1969

from

Cedarhurst, NY

Use our guide to learn which trials are right for you!